NIH-funded research R01 grant

New tools for modifying DNA and RNA nucleobases

Official title: DNAzymes for Site-Specific DNA and RNA Nucleobase Modification

Funded at University of Illinois at Urbana-Champaign · NIH-10901830 · Data updated 2026-11-12

This study is exploring new tools called DNAzymes that can change specific parts of DNA and RNA, which could help scientists better understand how these changes affect our bodies and lead to exciting new uses in medicine and technology.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Illinois at Urbana-Champaign
NIH-funded
Lab location1 site (Champaign, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2027
Funding year2024
Award (this year)$290,976
NIH project number5R01GM149566-02
Project IDNIH-10901830 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would include individuals with genetic conditions or diseases that could benefit from targeted DNA or RNA modifications.

Less likely to help

Patients with conditions unrelated to DNA or RNA modifications may not receive any benefit from this research.

What this research studies

This research focuses on developing innovative DNAzymes, which are artificial DNA sequences that can perform specific modifications on DNA and RNA nucleobases. By using a method called in vitro selection, researchers aim to create DNAzymes that can efficiently modify long nucleic acid substrates, overcoming current limitations in synthesizing modified nucleic acids. This approach could enhance our understanding of the biochemical and biological roles of nucleobase modifications, potentially leading to new applications in biotechnology and medicine.

Why it matters

Potential benefit: If successful, this research could lead to advanced techniques for modifying DNA and RNA, which may improve therapeutic strategies and diagnostic tools.

How similar studies have gone: While DNAzymes have shown promise in various applications, this specific approach to nucleobase modification is relatively novel and has not been extensively tested.

Where this research is happening

  • University of Illinois at Urbana-Champaign
    Champaign, United States
    Active

Researchers

  • Principal investigator: Silverman, Scott K — University of Illinois at Urbana-Champaign
  • Study coordinator: Silverman, Scott K

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.